8-K - Serina Therapeutics, Inc. - 5.02 / 5.03
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001708599-26-000027
Filing Date: 2026-04-21
Accepted: 2026-04-21 17:12:23
Documents: 12
Period of Report: 2026-04-15
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Serina Therapeutics, Inc. (Filer) CIK : 0001708599 (see all company filings) EIN. : 821436829 | State of Incorp.: AL | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 26880513 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | ser-20260415.htm iXBRL | 8-K
2 | EX-3.1 | ex31-changexproredlinexser.htm | EX-3.1
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ser-20260415.xsd | EX-101.SCH
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ser-20260415_lab.xml | EX-101.LAB